183 related articles for article (PubMed ID: 37073637)
1. Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study.
Arnold S; Mahrhold J; Kerstein-Staehle A; Riemekasten G; Csernok E; Hellmich B; Venhoff N; Thiel J; Affeldt K; Jahnke A; Lamprecht P
Clin Exp Rheumatol; 2023 Apr; 41(4):936-942. PubMed ID: 37073637
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
3. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.
Walker BS; Peterson LK; Koening C; White SK; Schmidt RL; Tebo AE
Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854
[TBL] [Abstract][Full Text] [Related]
4. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
Yoshida Y; Nakamoto N; Oka N; Kidoguchi G; Hosokawa Y; Araki K; Ishitoku M; Watanabe H; Sugimoto T; Mokuda S; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Hirata S
J Rheumatol; 2023 Sep; 50(9):1152-1158. PubMed ID: 37263656
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis.
Ahn SS; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2022 Nov; 37(6):1241-1249. PubMed ID: 34883552
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study.
Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2024 Jan; 43(1):367-376. PubMed ID: 37530864
[TBL] [Abstract][Full Text] [Related]
7. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
[TBL] [Abstract][Full Text] [Related]
8. ANCA associated vasculitis (AAV): a review for internists.
Yaseen K; Mandell BF
Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
[TBL] [Abstract][Full Text] [Related]
9. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
Trivioli G; Marquez A; Martorana D; Tesi M; Kronbichler A; Lyons PA; Vaglio A
Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort.
Liu S; Han L; Liu Y; Yang J; Zhang Y; Li M; Tian X; Zeng X; Wang L; Zhang F
Front Immunol; 2022; 13():885198. PubMed ID: 35833130
[TBL] [Abstract][Full Text] [Related]
11. IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
Padoan R; Gatto M; Ghirardello A; Tonello M; Franco C; Felicetti M; Schiavon F; Doria A
J Autoimmun; 2021 Nov; 124():102725. PubMed ID: 34534841
[TBL] [Abstract][Full Text] [Related]
12. Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Papo M; Sinico RA; Teixeira V; Venhoff N; Urban ML; Iudici M; Mahrhold J; Locatelli F; Cassone G; Schiavon F; Seeliger B; Neumann T; Kroegel C; Groh M; Marvisi C; Samson M; Barba T; Jayne D; Troilo A; Thiel J; Hellmich B; Monti S; Montecucco C; Salvarani C; Kahn JE; Bonnotte B; Durel CA; Puéchal X; Mouthon L; Guillevin L; Emmi G; Vaglio A; Terrier B;
Rheumatology (Oxford); 2021 Sep; 60(9):4355-4360. PubMed ID: 33347592
[TBL] [Abstract][Full Text] [Related]
13. Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives.
Pecher AC; Henes M; Henes JC
Arch Gynecol Obstet; 2023 Aug; 308(2):379-385. PubMed ID: 36104505
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis.
Monti S; Felicetti M; Delvino P; Padoan R; Berti A; Paolazzi G; Brunori G; Schiavon F; Caporali R; Montecucco C
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):107-113. PubMed ID: 34014158
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
16. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis.
Kim DS; Song JJ; Park YB; Lee SW
Int J Rheum Dis; 2017 Sep; 20(9):1261-1268. PubMed ID: 28261989
[TBL] [Abstract][Full Text] [Related]
17. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
19. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
Chang DY; Li ZY; Chen M; Zhao MH
Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
